Can spiritual workshops ease Cancer's existential pain?

NCT ID NCT07545291

First seen Apr 24, 2026 · Last updated Jun 23, 2026 · Updated 8 times

Summary

This study tests a spiritual health program called PATH for cancer patients struggling with feelings of disconnection, loss of meaning, or existential distress. Twenty adults with any stage of cancer will attend six workshops combining role-playing, psychology, and dignity therapy. The goal is to see if the program is feasible and acceptable, and whether it reduces spiritual distress and improves quality of life.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MALIGNANT SOLID NEOPLASM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Fred Hutch/University of Washington Cancer Consortium

    Seattle, Washington, 98109, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Spiritual therapy workshops

What this could lead to

If it works, this could offer a new way to help cancer patients cope with spiritual and existential distress, improving their quality of life.

What could go wrong

This is a very small, early feasibility study with only 20 participants. It is not designed to prove the therapy works, only that it can be tested. The intervention is subjective and may not help everyone.

Conditions

The condition(s) this trial relates to.

cancer hematopoietic and lymphoid system neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.